Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 9/20 | 0.55 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.45 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | MLKL | Q8NB16 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15116865 | 1.00 | AAK1 (0.55) | AAK1SSTR3SCN10ATRPV1MAP4K4 | |
| SCHEMBL15116803 | 1.00 | AAK1 (0.55) | AAK1SSTR3SCN10ATRPV1MAP4K4 | |
| SCHEMBL15116771 | 0.94 | AAK1 (0.51) | AAK1SSTR3SCN10ATRPV1MLKL | |
| SCHEMBL20054460 | 0.94 | AAK1 (0.51) | AAK1SSTR3SCN10ATRPV1MLKL | |
| SCHEMBL15125237 | 0.94 | AAK1 (0.54) | AAK1SSTR3SCN10ATRPV1MAP4K4 | |
| SCHEMBL15116826 | 0.91 | AAK1 (0.64) | AAK1SCN10ATRPV1MAP4K4MLKL | |
| SCHEMBL20054545 | 0.91 | AAK1 (0.64) | AAK1SCN10ATRPV1MAP4K4MLKL | |
| SCHEMBL15116595 | 0.90 | AAK1 (0.45) | AAK1SSTR3SCN10ATRPV1LCK | |
| SCHEMBL20221495 | 0.90 | AAK1 (0.45) | AAK1SSTR3SCN10ATRPV1LCK | |
| SCHEMBL19414754 | 0.87 | SSTR3 (0.46) | AAK1SSTR3SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2802326-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-18 | — | — | EP | disclosed |